Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Experic announced a strategic collaboration with Flurry Powders to bring together complementary expertise to accelerate development of next generation therapies requiring advanced particle engineering.
read more
Southwest Research Institute (SwRI) has opened a new 21,000-square-foot Clinical Supply Facility (CSF) designed to expand its pharmaceutical development and bioengineering capabilities in San Antonio, Texas.
read more
Piramal Pharma Solutions announced the installation of a Korsch X3 high containment tablet press at its integrated API and oral solid development and manufacturing site in Morpeth, UK.
read more
StarLIMS has agreed to acquire the MODA® Platform, a solution for manufacturing quality assurance and control in regulated environments. The transaction is expected to close in Q2 2026, subject to customary closing conditions.
read more
Perceptive eClinical and Kayentis have announced a strategic alliance to provide a fully integrated electronic Clinical Outcome Assessment (eCOA) and Interactive Response Technology (IRT) solution for global clinical trials.
read more
Monash University and ClinChoice announced a strategic partnership designed to fast-track early-phase clinical trials and bring groundbreaking health innovations and discoveries closer to patients worldwide.
read more
OFD Life Sciences, a division of Oregon Freeze Dry, has been awarded a patent for its LyoPastille oral delivery platform, an orally dissolving tablet (ODT) technology.
read more
Cambrex announced the completion of initial engineering studies for its new, large-scale active pharmaceutical ingredient (API) manufacturing plant in Charles City, Iowa.
read more
Axplora has announced a major milestone in its $60 million investment program to expand highly potent API (HPAPI) development and manufacturing at its Farmabios site in Gropello Cairoli, Italy.
read more
ESTEVE CDMO announced that it would add to its plans for the buildout of a new production unit at its facility in Celrà and launch a new brand identity.
read more
LGM Pharma has announced the second phase of its CDMO growth strategy, committing an additional $9 million to its drug product manufacturing facilities in Rosenberg, Texas, and Colorado Springs, Colorado.
read more
Cellipont Bioservices announced a strategic collaboration with BobcatBio, a clinical-stage biotechnology company that is pioneering the development of RB-1355, a first of its kind cellular therapy that leverages the versatility and power of a patient...
read more
MedPharm reported that it is supporting Palvella Therapeutics following Palvella’s announcement of positive topline results from the Phase 3 SELVA study of QTORIN 3.9% rapamycin anhydrous gel in microcystic lymphatic malformations (microcystic LMs).
read more
BioCina announced it has initiated a comprehensive CMC (Chemistry, Manufacturing, and Controls) program for the advancement of RLS-2201, a proprietary injectable formulation of Quetiapine being developed by Patrys for the acute treatment of delirium ...
read more
AptarGroup announced that its proprietary nasal delivery system is being utilized in LTR Pharma Limited’s Phase II clinical study of SPONTAN®, an investigational intranasal spray under development for the treatment of erectile dysfunction.
read more